Search
Navigation
Join our mailing list!
(Your shopping cart is empty)
Home
>
Diane Publishing Books
>
Prescription Drugs: FDA Has Met Most Performance Goals for Reviewing Applications
Our Price:
$
25.00
By
Marcia G. Crosse (au)
Year:
2012
Pages:
52
Binding
Paperback
ISBN
978-1-4578-3201-7
Product Code:
1457832011
Description
The FDA is responsible for overseeing the safety and efficacy of drugs and biologics sold in the U.S. New drugs and biologics must be reviewed by FDA before they can be marketed. The FDA reviews new drug applications (NDA), biologic license applications (BLA), and efficacy supplements that propose changes to the way approved drugs and biologics are marketed or used. This report: (1) examines trends in FDAäó»s NDA and BLA review performance for FY 2000 through 2010; (2) examines trends in FDAäó»s efficacy supplement review performance for FYs 2000 through 2010; and (3) describes issues that have been raised about the drug and biologic review processes and steps FDA is taking that address them. A print on demand report.
Related Products...
Guide to Metal Toys
Our Price:
$22.00
Add
American Short Story, 1945-1980: A Critical History
Our Price:
$13.00
Add
American Vegetarian Resource Directory: Some Signposts on the Journey Towards a Healthier, More Ethically & Environmentally Balanced Lifestyle
Our Price:
$7.00
Add
Supporting the Sky
Our Price:
$24.00
Add
Suggestions of Abuse: True & False Memories of Childhood Sexual Trauma
Our Price:
$22.00
Add
Share your knowledge of this product with other customers...
Be the first to write a review
Diane Publishing Co
PO Box 617
Darby, PA 19023-0617
1-800-782-3833
About Us
Become an Affiliate
Privacy Policy
Send Us Feedback
Company Info
|
Advertising
|
Product Index
|
Category Index
|
Help
|
Terms of Use
Copyright � 2004 Diane Publishing Company. All Rights Reserved.
Built with
Volusion